ATS Comments and Testimony
ATS Comments on the Affordable Care Act
- March 2018 ATS Comments on Association Health Plans
- November 2017 Comments on ACA Insurance Standards
- ATS Letter Urging Congress to Maintain Insurance Coverage in ACA Repeal and Replace Efforts
- ATS Comments on the ACA Essential Health Benefits Package
- ATS Comments on ACA Medicaid Expansion
Congress and Courts
- 11/14/18: Letter to Congress supporting ACE Kids Act
- 7/17/18: ATS Amicus Brief - AAP v FDA E-cigarettes
- 4/26/18: ATS Testimony to House Labor-HHS Appropriations Subcommittee on NIH and CDC Programs
- 12/15/17: ATS Letter on Final Tax Bill
- 12/13/17: ATS Letter on CHIP Funding Reauthorization
- 12/1/17: Letter Supporting CDC Chronic Disease Funding
- 4/7/17: U.S. House of Representative NIH Letter and List of Signors
- 4/1/16: ATS Amicus Brief - WV v EPA Clean Power Plan 2016
- 1/27/16: ATS Recommendations to the U.S. Senate Finance Committee in response to Bipartisan Chronic Care Working Group's Policy Options Document
- 03/01/13: ATS Testimony to the House State, Foreign Ops & Related Agencies Approps. Sub. Comm. on the TB Program FY2014 Funding
- 03/23/11: ATS Testimony before the House Mil/Con/VA Appropriations Subcommittee on VA Research Funding
Congressional Letters
- NHLBI Constituency Group letter to Congress supporting NHLBI COVID-19 Research Funding
- May 2020 Letter to Congress Requesting Financial Relief for Pediatric Providers
- 2019 Senate Domestic TB Appropriations Letter
- Letter to Congress Supporting PCORI Renewal
Federal Agencies
- 04/08/2020: S-Far Letter to CDC on Secondary Infections and Antibiotic Resistance
- 12/21/2018: Letter to HHS Secretary Supporting Fetal Tissue Research
- 12/10/2018: Jonathan Samet MD MS and colleagues – Proposed Changes to CASAC Review Process
- 12/07/2018: ATS Comments on Public Charge Determinations (Immigrant Health)
- 08/31/2018: ATS Comments to NIGMS on Accelerating Sepsis Research
- 08/10/2018: ATS Comments on Asbestos; Significant New Use Rule
- 07/16/2018: ATS Comments on Trump Administration Drug Pricing Blueprint
- 12/14/17: December 2017 thanking FDA for Stem Cell Therapeutics
- 09/02/14: ATS comment to CMS on 2015 Medicare Physician Fee Schedule
- 09/02/14: ATS comments to CMS on 2015 Hospital Outpatient Prospective Payments
- 08/31/12: ATS Comments on Medicare Programs: Revisions to Payment Policies Under Physician Fee Schedule
- 02/17/12: ATS Comments on the proposed rules of section 6002 of the Affordable Care Act (ACA)
- 11/23/11: ATS Comments to EPA on Primatene Mist Phase-Out
- 10/31/11: ATS Comments Filed with DOT on Smoking of Electronic Cigarettes on Aircraft
- 09/26/11: ATS Comments to CMS on Health Insurance Exchanges
- 08/26/11: ATS Comments to CMS on the Proposed 2012 Medicare Physician Fee Schedule
- 06/06/11: ATS Comments to CMS on the Creation of Accountable Care Organizations
- 06/06/11: ATS Comments to CMS on the creation of Accountable Care Organizations (ACO)'s
Medicaid
Other Public Comments
- March 2018, AHRQ Annual Funding Letter
- Letter to Department of Transportation regarding withdrawl of Sleep Apnea Screening
- Ad Hoc Group for Medical Research Letter on 2017 NIH Funding
- Joint Internal Medicine Letter Opposing Immigration Ban
- Coalition Letters Opposing House and Senate FY 2016 AHRQ Funding Cuts
- ATS Policy Brief on Clean Air
- Statement on EPA's Power Plant Air Toxics Rule
- ATS letter to Joint Committee on Deficit Reduction Committee
- Comment on OHRP Proposed Revisions to Human Research Protections
